Seth Klarman · Q4 2013
Baupost Group
Portfolio at the end of Q4 2013, from the 13F filed February 13, 2014. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Micron Technology MU · history | 31.8% | Q2 2013 or earlier | Reduce 19% |
| Innoviva INVA · history | 20.3% | Q2 2013 or earlier | Add 9% |
| Viasat VSAT · history | 19.8% | Q2 2013 or earlier | Add 1% |
| BP BP · history | 7.8% | Q2 2013 or earlier | Add 1% |
| Idenix Pharmaceuticals IDIX · history | 6.3% | Q2 2013 or earlier | Add 24% |
| Citigroup C.WS · warrants · history | 1.9% | Q2 2013 or earlier | Add 11% |
| Fidelity National Financial FNF · history | 1.8% | Q4 2013 | Buy |
| ChipMOS IMOS · history | 1.8% | Q2 2013 or earlier | No change |
| PBF Energy PBF · history | 1.8% | Q3 2013 | Add 107% |
| Novagold Resources NG · history | 1.6% | Q2 2013 or earlier | No change |
| Syneron Medical ELOS · history | 1.4% | Q2 2013 or earlier | No change |
| Adeia ROVI · history | 1.2% | Q2 2013 or earlier | Reduce 65% |
| Kindred Biosciences KIN · history | 0.9% | Q4 2013 | Buy |
| Pyxus International AOI · history | 0.6% | Q2 2013 or earlier | No change |
| American International Group AIG.WS · warrants · history | 0.4% | Q2 2013 or earlier | No change |
| Trilogy Metals TMQ · history | 0.2% | Q2 2013 or earlier | No change |
| AVEO Oncology AVEO · history | 0.2% | Q2 2013 or earlier | No change |
| Alon USA Partners ALDW · history | 0.2% | Q4 2013 | Buy |
| Enzon Pharmaceuticals ENZN · history | 0.1% | Q2 2013 or earlier | Reduce 44% |
| 19 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2013, adjusted for stock splits.
Sector weighting
| Technology | 34.8% | |
|---|---|---|
| Health care | 29.3% | |
| Media & telecom | 19.8% | |
| Energy | 9.7% | |
| Financials & real estate | 4.1% | |
| Materials | 1.8% | |
| Consumer staples | 0.6% |
What changed from Q3 2013
- Buy Fidelity National Financial FNF 1.8% of the 13F
- Buy Kindred Biosciences KIN 0.9% of the 13F
- Buy Alon USA Partners ALDW 0.2% of the 13F
- Add 9% Innoviva INVA 21.6% → 20.3%
- Add 1% Viasat VSAT 20.0% → 19.8%
- Add 1% BP BP 6.7% → 7.8%
- Add 24% Idenix Pharmaceuticals IDIX 4.4% → 6.3%
- Add 11% Citigroup C.WS 2.0% → 1.9%
- Add 107% PBF Energy PBF 0.6% → 1.8%
- Reduce 19% Micron Technology MU 32.0% → 31.8%
- Reduce 65% Adeia ROVI 3.4% → 1.2%
- Reduce 44% Enzon Pharmaceuticals ENZN 0.4% → 0.1%
- Sell Oracle ORCL was 2.3%
- Sell Micron Technology MU.CV was 0.5%
- Sell Central Pacific Financial CPF was 0.4%
- Sell Ituran Location & Control ITRN was 0.3%